A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors

Completed

Conditions studied: Uterine Cancer, Cervix Uteri Nos, Gestational Trophoblastic Disease

In brief

The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life. We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.

Key facts

Study ID

NCT00706875

Run by

Memorial Sloan Kettering Cancer Center

People needed

59

Starts

2008-06-01

Expected to finish

2018-04-01

Last updated by the study team

2018-04-30

Who can join

Age: 18 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pathology confirmed GTD by MSKCC
• Sufficient proficiency in the English language to respond to quality of life surveys
• Age ≥ 18 years
• Benign or malignant disease
• Treated with surgery and/or chemotherapy or observation

You may not qualify if…

• None

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.